Skip to main content
. Author manuscript; available in PMC: 2016 Dec 23.
Published in final edited form as: J Nanomed Nanotechnol. 2016 Oct 28;7(5):404. doi: 10.4172/2157-7439.1000404

Figure 2.

Figure 2

T1-weighted MR images, pre-injection (A) and post-injection (B) of GdDOTA-G4-DL680 nanoparticle in a subcutaneous flank tumor mouse model of MDA-MB-231 TNBC (dotted red circle). The agent was injected i.v. at 0.04 mmol/kg Gd dose, and detected using a T1-weighted MRI method at 7T Varian scanner. (C) Hematoxylin-eosin staining of MDA-MB-231 tumor (T).